Advanced or Metastatic NRAS-mutant Melanoma
1 clinical trials · Condition
◉ Watch Advanced or Metastatic NRAS-mutant Melanoma
| Record | Firm | Date |
|---|---|---|
| A Study to Assess Naporafenib (ERAS-254) Administered With Trametinib in Patients With NRAS-mutant Melanoma (SEACRAFT-2) (NCT06346067) | Erasca, Inc. | 2024-04-29 |
Track Advanced or Metastatic NRAS-mutant Melanoma automatically
Every clearance here is in the API, with alerts when new ones post.